Physician profile
William Simpson
NPI 1871282129
$1,718.45
in general payments reported to CMS, 2019-2025
13 companies · $301 in 2025
The $301 reported for 2025 was more than what a typical Surgical provider received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $316 · 2024: $1,101 · 2025: $301.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,175 · Travel and Lodging: $544.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,174.61 |
| Travel and Lodging | $543.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $742.38 | 2024 | Iovera, Exparel |
| Amgen INC. | $282.79 | 2023-2025 | Evenity, Prolia, Prolia |
| Stryker Corporation | $222.54 | 2023-2024 | Mako, Triathlon, Gamma |
| Depuy Synthes Sales INC. | $143.76 | 2024 | Na |
| Fidia Pharma USA INC. | $64.36 | 2024 | Hymovis, Triluron, Hyalgan |
| Heron Therapeutics, INC. | $51.37 | 2024-2025 | Zynrelef |
| Vertex Pharmaceuticals Incorporated | $48.11 | 2024-2025 | |
| Smith+Nephew, INC. | $38.43 | 2025 | Renasys Touch |
| Ferring Pharmaceuticals INC. | $36.29 | 2024-2025 | Euflexxa |
| Biocomposites INC | $29.10 | 2025 | Stimulan |
| Innovation Technologies INC | $25.49 | 2024 | Irrisept |
| Bioventus LLC | $21.95 | 2025 | Durolane |
| Heraeus Medical, LLC. | $11.88 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Simpson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.